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Abstract. A Tyr to Cys mutation at amino acid position 
723 in the cytoplasmic domain of the simian immuno- 
deficiency virus (sir) transmembrane (TM) molecule 
has been shown to increase expression of envelope gly- 
coproteins on the surface of infected cells. Here we 
show that Tyr-723 contributes to a sorting signal that 
directs the rapid endocytosis of viral glycoproteins from 
the plasma membrane via coated pits. On ceils infected 
by SIVs with a Tyr at position 723, envelope glycopro- 
teins were transiently expressed on the cell surface and 
then rapidly endocytosed. Similar findings were noted 
for envelope molecules expressed in the absence of 
other viral proteins. Immunoelectron microscopy dem- 
onstrated that these molecules were localized in 
patches on the cell surface and were frequently associ- 
ated with coated pits. In contrast, envelope glycopro- 
teins containing a Y723C mutation were diffusely dis- 
tributed over the entire plasma membrane. To 
determine if an internalization signal was present in the 
SIV TM, chimeric molecules were constructed that con- 
tained the CD4 external and membrane spanning do- 
mains and a SIV TM cytoplasmic tail with a Tyr or 
other amino acids at SIV position 723. In Hela cells sta- 
bly expressing these molecules, chimeras with a Tyr-723 
were rapidly endocytosed, while chimeras containing 
other amino acids at position 723, including a Phe, were 
internalized at rates only slightly faster than a CD4 
molecule that lacked a cytoplasmic domain. In addi- 
tion, the biological effects of the internalization signal 
were evaluated on infectious viruses. A mutation that 
disrupted the signal and as a result, increased the level 
of viral envelope glycoprotein on infected cells, was as- 
sociated with accelerated infection kinetics and in- 
creased cell fusion during viral replication. These re- 
suits demonstrate that a Tyr-dependent motif in the 
SIV TM cytoplasmic domain can function as an inter- 
nalization signal that can modulate expression of the vi- 
ral envelope molecules on the cell surface and affect 
the biological properties of infectious viruses. The con- 
servation of an analogous Tyr in all human and simian 
immunodeficiency viruses suggests that this signal may 
be present in other primate lentiviruses and could be 
important in the pathogenesis of these viruses in vivo. 
T 
HE glycoproteins of enveloped viruses play an im- 
portant  role in  the viral  life cycle. They perform 
critical  functions during  viral  entry  and  assembly 
and serve as principle targets of humoral and cellular im- 
mune  responses  (Hunter  and  Swanstrom,  1990).  These 
proteins are synthesized in the rough endoplasmic reticu- 
lum of the infected cell, processed during trafficking along 
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the  exocytic pathway,  and  selectively incorporated  into 
budding virions.  During  viral  assembly, interactions  be- 
tween the cytoplasmic domains of these envelope glyco- 
proteins and internal proteins of the virion likely influence 
the site of viral budding (Rhee and Hunter, 1990; Owens 
et al., 1991; Lodge et al., 1994), the incorporation of enve- 
lope proteins  into  virions  (Whitt  et  al.,  1989; Gaedigk- 
Nitschko and Schlesinger,  1991; Lyles et al., 1992; Bilsel et 
al.,  1993; Gray  and  Roth,  1993; Naim  and  Roth,  1993; 
Zhao et al., 1994), and the infectivity of the viral particle 
(Granowitz et al., 1991; Dubay et al., 1992; Johnston et al., 
1993; Yu et al., 1992, 1993; Owens and Rose, 1993; Brody 
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dence that envelope glycoproteins interact with cellular 
proteins that affect their transport to, mobility and expres- 
sion on the cell surface (Doyle et al., 1985; Lazarovits et 
al., 1990; Lydy and Compans, 1993). However, the specific 
cellular factors and viral determinants involved in these in- 
teractions are poorly understood, as is their role in viral 
pathogenesis. 
For the human and simian lentiviruses, human immuno- 
deficiency virus (HI  V)t-1, HIV-2, and simian immunodefi- 
ciency virus (SIV), the surface (SU) and transmembrane 
(TM) glycoproteins are transported as complex oligomers 
to the cell surface where they are incorporated into bud- 
ding virions (Allan et al., 1985; Kowalski et al., 1987; Wil- 
ley et al., 1988; Chakrabarti et al., 1990; Earl et al., 1990; 
Stein and Engleman, 1990; Doms et al.,  1993).  Although 
the TM cytoplasmic domains of these glycoproteins are 
not required for processing or transport to the cell surface 
(Dubay et al., 1992; Gabuzda et al., 1992; Johnston et al., 
1993), these domains can affect the site of budding in po- 
larized cells (Owens et al., 1991; Lodge et al., 1994), the in- 
corporation of envelope glycoproteins into virions (Dubay 
et al., 1992; Yu et al., 1993; Brody et al., 1994), the confor- 
mation of the envelope glycoprotein ectodomain (Spies et 
al., 1994), the ability of the envelope to induce cell fusion 
(Mulligan et al., 1992; Ritter et al., 1993; Spies and Corn- 
pans, 1994), and the infectivity of the viral particle (Dubay 
et al., 1992; Gabuzda et al., 1992; Johnston et al., 1993; 
Salzwedel et al., 1993; Yu et al., 1993).  Interestingly, for 
SIV the TM cytoplasmic domain has also been implicated 
in modulating the expression of envelope molecules on the 
cell surface, since SIVs with prematurely truncated or ab- 
sent cytoplasmic tails express increased levels of envelope 
proteins on the plasma membrane (Johnston et al., 1993; 
Zingier and Littman, 1993). These findings could be rele- 
vant to biological changes associated with premature ter- 
mination codons that spontaneously occur when SIVs are 
propagated in human cells (Kodama et al., 1989; Johnston 
et al., 1993; Ritter et al., 1993).  Given the importance of 
cell-associated viral glycoproteins in mediating cytopathic 
effects and as targets of humoral and cellular immune re- 
sponses, it is likely that the extent to which envelope gly- 
coproteins are expressed on the plasma membrane could 
influence the pathogenesis of these viruses in vivo. None- 
theless, viral and cellular mechanisms that modulate the 
expression of envelope molecules on the cell surface re- 
main to be determined. 
We have previously described a variant of SIVmac de- 
rived from the BK28 molecular clone, termed CP-MAC, 
that exhibits a remarkably high level of surface envelope 
glycoprotein on  infected cells  (LaBranche et  al.,  1994). 
The determinant for this effect was shown to be a single 
amino acid mutation of a Tyr to a Cys at position 723 in 
the  TM  cytoplasmic domain  (LaBranche  et  al.,  1995). 
However, no differences were found in the kinetics or effi- 
ciency of envelope glycoprotein processing or in the trans- 
1. Abbreviations  used in thispaper.  HEp, human epidermal cells; HIV, hu- 
man immunodeficiency virus; LDL, low density lipoprotein; LDLr, low 
density lipoprotein receptor; MA, matrix; nt, nucteotide; RT, reverse tran- 
scriptase; SFV, Semiiki Forest virus; SIV, simian immunodeficiency virus; 
SU, surface; TM, transmembrane. 
port of these molecules to the cell surface. We now show 
that Tyr-723 contributes to a signal that directs the rapid 
and efficient endocytosis of envelope molecules from the 
cell surface via clathrin-coated pits. This effect could be 
shown on virus-infected cells as well as on ceils expressing 
envelope glycoproteins in the absence of other viral mole- 
cules. The SIV TM cytoplasmic tail could mediate efficient 
endocytosis of a heterologous molecule, CD4, when it was 
used to replace the CD4 cytoplasmic domain, and this ac- 
tivity was shown to depend on Tyr-723.  In addition, by 
modulating the  level  of viral  glycoproteins on  infected 
cells, this signal was shown to effect the infectivity as well 
as the cytopathic properties of the virus during replication 
in  vitro.  Together  these  results  indicate  that  SIV  has 
adopted a cellular membrane protein sorting signal to reg- 
ulate the expression of its envelope proteins on the surface 
of infected cells, and suggest that this signal may contrib- 
ute to viral pathogenesis in vivo. 
Materials and Methods 
Cell Lines 
The CD4 + T-cell lines Sup-T1, HUT-78, and CEMx174 have been de- 
scribed previously (LaBranche et al., 1994).  HeLa cells were obtained 
from M. Malim (University of Pennsylvania, Philadelphia, PA). BHK-21 
cells and human epidermal carcinoma (HEp2) cells were obtained from 
the European Molecular Biology Laboratory (Heidelberg, Germany) and 
C.R.  Hopkins  (MRC  Laboratory of Molecular  Cell Biology, London, 
UK), respectively. PA317, a murine fibroblast packaging cell line was ob- 
tained  from  the  American Type  Culture  Collection  (Rockville,  MD) 
(CRL 9078). Human T lymphoid cell lines were maintained in RPMI sup- 
plemented with 10% fetal calf serum. BHK-21 cells were maintained in 
Glasgow's modified Eagle's medium supplemented with  10%  tryptose 
phosphate broth, 5%  FCS, penicillin, and streptomycin (G-MEM). All 
other lines were maintained in DME supplemented with 10% FCS. 
Viruses 
The  infections molecular clone of SIVmac, BK28,  was obtained from 
James Mullins (University of Washington, Seattle, WA) through the Na- 
tional Institutes of Health AIDS Research and Reference Reagent Pro- 
gram (Kornfeld et al., 1987).  The laboratory-derivod variants of BK28, 
designated NC-MAC and CP-MAC, have been described (LaBranche et 
al., 1994, 1995).  Relative to BK28, CP-MAC contained five amino acid 
substitutions in SU (E84K, R112K, R120K, M327R, T475I), five in the 
TM  ectodomain (L559S,  V573L,  K757T,  T588I,  E643K),  and  a  single 
amino acid mutation (Y723C) in the TM cytoplasmic tail. NC-MAC con- 
tained four amino acid mutations in SU (E84K, R112K, R120K, G385R) 
and no mutations in TM. BK/NC-723Y was constructed using a  3.5-kb 
SacI fragment (nucleotides [nts]  5735-9212)  containing the  entire  env 
gene of NC-MAC and a molecular clone of BK28 from which this corre- 
sponding SacI fragment had been deleted. BK/NC-723C was constructed 
by inserting an NheI-PstI (nts 8724-8947) fragment from the CP-MAC env 
gene into the BK/NC-723Y env. The  env of BK/NC-723C was identical to 
that of BK/NC-723Y except for the presence of the Y723C mutation. BK/ 
723C was produced by inserting this same NheI-PstI fragment from CP- 
MAC into the BK28 env gene. 
Monoclonal Antibodies 
Murinc mAbs used for detection of SIV proteins included 43.1 and 3A8, 
reactive with SIVmac TM and p27  gag, respectively (provided by J. Mc- 
Clure, Bristol-Myers Squibb, Seattle, WA) and 101.1, reactive with SIV- 
mac SU (provided by C. Thidart, SmithKline Biologicals, Rixensart, Bel- 
gium). The anti-CD4 mAb Q4120 was obtained from Q. Sattentau, Centre 
d'Immunology de Marseille-Luminy, France through the Medical Re- 
search Council AIDS Directed Programme Reagents Programme. The 
anti-CD4 mAb, No. 21 was developed in our laboratory from BALB/c 
mice immunized with Snp-Ti and is an IgG~ that has been shown to react 
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completely inhibits CP-MAC-indueed fusion of Sup-T1 cells. Fab frag- 
ments of mAb 101.1 were prepared using the ImmnnoPure Fab prepara- 
tion Kit (Pierce Chemical Co., Rockford, IL). Negative control mAbs in- 
eluded  P3x63  (IgG2b)  or  nonreactive  IgG  mAbs  produced  in  our 
laboratory. 
Expression of env Constructs 
Expression of the viral envelope proteins, was performed using the Sem- 
liki Forest virus (SFV) expression system (Liljestr6m and Garoff, 1991). 
To express the CP-MAC env, 3.5-kb SacI fragments containing the entire 
env gene of CP-MAC with a BamHI site close to the 3' end were ligated 
and cut with BamHI to generate a fragment containing one complete copy 
of the env  gene with BamHI ends. This fragment was ligated into the 
BamHI site of the eukaryotic expression vector pGWb provided by S. 
Moss (MRC-LMCB, London, UK) (Moss et al., 1990).  A  novel BamHI 
site was engineered 17-bases upstream of the env start codon to remove 
most of the 5' untranslated sequence using an (Muta-Gene M13; Bio-Rad 
Laboratories, Cambridge, MA) in vitro mutagenesis kit and the mutagen- 
esis primer  3'-CATACTTACTrGTTGGATCCAGAAGATGTATTA- 
5'. The mutant env gene was cut from pGW1 with BamHI and cloned into 
pSFV 1 to generate the pSFVl:CP-MAC/723C expression vector. A similar 
strategy was used to generate a  pSFV1 vector expressing the BK28  env 
gene, designated pSFV1:BK28F/23Y.  The pSFV1:CP-MAC/723Y  vector 
was constructed by inserting a  376-bp NheI-BgllI fragment from BK28 
into the CP-MAC env cloned into pGW~. The env gene was then cut with 
BamHI and cloned into pSFV  1. 
Recombinant SFV viruses were generated essentially as described (Lil- 
jestr6m and Garoff, 1991).  pSFV  1 and pSFVhelp~r constructs were linear- 
ized with Nrul and SpeI, respectively, and transcribed in vitro using SP6 
polymerase  (Pharmacia  Fine  Chemicals).  RNA  was  co-electroporated 
into BHK-21 cells and the transfected cells were plated in G-MEM and 
grown at 37°(2/5%  CO2. After 36 h, the virus-containing medium was col- 
lected,  clarified  by centrifugation  (3,000  rpm,  10 rain),  aliquoted,  and 
stored at -70°C. Viral stocks were titered on BHK-21 or HEp2 cells. 
For analysis of the env proteins, BHK-21 or HEp2 cells were grown on 
glass coverslips to approximately 50% confluence in 16-mm-diam wells. 
Virus stocks were diluted in binding medium, BM (RPMI-1640 without bi- 
carbonate, 10 mM Hepes, 0.2% BSA, pH 6.8). Cells were washed twice 
and following addition of virus (200 p.l/well)  were incubated for 1.5 h at 
37°C. 1 ml G-MEM or DME was added per well of BHK-21 or HEp2 
cells, respectively, and the cells incubated at 37°C for 16 h. Cells were then 
washed with cold PBS, fixed with 3%  paraformaldehyde in PBS for 10 
min at room temperature, and quenched with 50 mM NI-~C1 in PBS and 
processed for immunofluorescence microscopy as described below. 
Construction and Expression of CD41SIV-TM 
Chimeric Proteins 
Chimeric proteins containing the CD4 ecto- and membrane spanning do- 
mains and  SIV  TM cytoplasmic tails were  constructed by introducing 
unique HindIII sites into CD4 (at either nt 1336 or 1351) and into the 
BK28 env gene (at nt 8731). Mutagenesis was performed by PCR on 
the pT4b molecular clone of CD4 (provided by D. Littman, New York 
University, New York), cloned into the EcoR1 site of sp65 (Promega Bio- 
tec, Madison, WI). Primer pairs used to generate CD4 chimeras in which 
the cytoplasmic domain was entirely replaced by SIV sequences were, for- 
ward primer, 5'-GGAAGTGTCTGTAAAACGGG-3' (nts 852-871) and 
reverse  primer,  5'-GCCGAAGCTTGACACAGAAG-3'  (nts  1345- 
1325).  For  CD4 chimeras containing four amino acids of the predicted 
CD4 cytoplasmic domain, the reverse primer 5'-GGCGAGCTTTCGGT- 
GCCGGCACCTGAC-3' (nts 1356-1333) was used (see Fi  B. 6). The re- 
suiting fragments were digested with BstE2 and HindIII and cloned into 
pT4b. SIV TM constructs were generated by PCR on BK28 with the for- 
ward  primer,  5'-GCTAGCTAAGC'ITAGGCAGG-3'  (nts  8724-8743) 
and the reverse primer, 5'-AATAGCGAATTCAAGAGGCGT-3' (nts 
8936-8916). In addition to creating a 5' HindIII site, these primers created 
a 3' EcoRI cloning site. TM fragments were also generated that incorpo- 
rated Cys, Phe, Ala, Ile, or Ser mutations at Tyr-723. TM fragments were 
digested with HindIII and EcoRI and cloned into sp64 (Promega Biotec). 
The  CD4-containing sp65 and SIV TM-containing sp64 plasmids were 
then digested with PvuI and HindlII  and ligated to generate an EcoRI 
fragment encoding the CD4/SIV chimeric proteins. The CD4/LDLr chi- 
mera was generated using a similar strategy in which an LDLr molecular 
clone (provided by N. Landau, Aaron Diamond AIDS Research Center, 
New York) was amplified (forward primer, 5'-TGGAAGCTITGGCG- 
GCTrAAGAACATC-3'; reverse primer, 5'-GCAGAATrCGGCGAG- 
GTCTCAGGAAGG-Y) to generate a 5' HindIII junction site at the be- 
ginning of the cytoplasmic domain and a 3' EcoRI cloning site after the 
native stop codon.  This fragment was cloned into sp64 and ligated  as 
above to generate the construct shown in Fig. 6. A  CD4/tail-minus con- 
strnct with a premature termination codon at Arg-400 of CD4 was gener- 
ated from the CD4 eDNA cloned into pGWl by site directed mutagenesis 
using the BioRad Muta-Gene M13 in vitro mutagenesis kit and the mu- 
tagenesis primer, 3'-CACGGCCGTGACITCCGCGGTI'C-5'. All con- 
struets were cloned into the EcoRI site of the Moloney murine leukemia 
virus expression vector pMV-6 (Kirschmeier et al., 1988). 
To generate HeLa clones stably transfected with the chimeric mole- 
cules, the amphotropic packaging line, PA317, was transfected with 30 Ixg 
of plasmid DNA by the calcium phosphate method. After 24 h, the cells 
were washed and incubated in DME/10% FCS for 24 h. The virus-con- 
taining supernatant was then filtered (0.45  p~m) and supplemented with 
polybrene (8 I~g/ml; Sigma Chemical Co., St. Louis, MO) before infecting 
HeLa cells for 24 h. After infection, the HeLa cells were trypsinized and 
diluted into DME/10% FCS containing 400 i~g/ml G418 for selection of 
resistant colonies. Clones were screened for expression of the chimeric 
protein by immunofluorescence microscopy and flow cytometry with an 
anti-CD4 mAb. 
Immunofluorescence Microscopy 
For detection of viral proteins on SIV-infected Sup-T1 cells, or on HeLa 
cells expressing chimeric proteins, cells were fixed with methanol and ace- 
tone (1:1) at room temperature for 10 min and stained with anti-SIV SU, 
TM, or p27s"g mAbs or an anti-CD4 mAb followed by FITC-conjugated 
F(ab')2 goat anti-mouse IgG (Biosource International or Pierce). For de- 
tection of env proteins expressed by pSFV l, surface staining was deter- 
mined by fixing cells in 3% paraformaldehyde prior to staining. For exper- 
iments in which access to intracellular antigens was required, cells were 
permeabilized by incubation in 0.1% Triton X-100. Stained coverslips or 
slides were mounted in Moviol and viewed using a Zeiss Axioskop fluo- 
rescence microscope. 
Endocytosis Assays 
Endocytosis of SIV envelope glycoproteins was evaluated using immuno- 
fluorescence microscopy. For cells chronically infected by SIVs, cells were 
incubated at 37°C with a  1/1,000  dilution of anti-SU mAb ascites (101.1), 
and at various times, aliquots of cells were chilled to 4°C and surface anti- 
body removed with acid elution buffer (RPMI/0.2%  BSAJ10 mM MES, 
pH 2.5). Cells were then permeabilized with methanol/acetone (1:1) and 
stained with FIT~-conjugated F(ab')2 goat anti-mouse IgG. For assays 
performed on env-expressing BHK-21 or HEp2 cells, cells grown on glass 
coverslips were incubated for 14 h at 37*(2 with 10 pfu/cell of pSFV~. Me- 
dium was  then  supplemented with  a  1/1,000  final  dilution  of anti-SU 
(101.1) or anti-TM mAb (43.1) ascites for an additional 2 h. Cells were 
washed, fixed in 3%  paraformaldehyde, and stained with a  rhodamine- 
conjugated goat anti-mouse IgG (Pierce Chemical Co.), either before or 
after permeabilization with 0.1% Triton X-100. Where indicated surface 
antibody was removed before fixation with acid elution buffer. 
A  quantitative assay for endocytosis of CD4-based constructs was per- 
formed as described previously (Pelchen-Matthews et al., 1989).  Briefly, 
HeLa cells stably expressing various CD4/SIV constructs were seeded at 
30-50,000 per well in 24 x  16 mm  2 well plates and grown for 2 d  (final 
density ~1-2 x  105 cells/well). For analysis the cells were cooled on ice, 
washed with BM and incubated with 0.3-0.4 nM 125I-Q4120 for 2 h on ice. 
Unbound mAb was removed by washing with cold BM and the cells were 
warmed to 37°C for the indicated times to allow endocytosis to occur. 
Cells were chilled on ice and for each time point the total cell-associated 
and internalized lzSI-Q4120  determined by either harvesting the cells di- 
rectly or following removal of the remaining cell surface mAb by washing 
in acid medium. 125I-Q4120 was determined by 7 counting. The proportion 
of internalized activity for each time point was determined by dividing the 
acid-resistant activity by the total cell-associated activity and endocytic 
rates were calculated by analysis of data from the first 5 min of warm-up. 
Flow Cytometry 
FACS  ® analysis of cell surface molecules was performed as previously de- 
scribed using a  FACScan  ® flow cytometer  (Becton  Dickinson &  Co., 
Mountain View, CA) (LaBranche et al., 1994). Sup-T1 cells chronically in- 
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bated in staining buffer (PBS supplemented with 0.1% BSA and 0.02% 
sodium azide) with saturating concentrations of mAbs (30 rain for 4°C) 
followed by FITC-conjugated secondary antibody (30 rain for 4°C). Cells 
were washed and fixed in 4% paraformaldehyde before analysis with Ly- 
sis-II software (Becton Dickinson & Co.). 
Western Blotting and Immunoprecipitation 
HeLa lines expressing CD4-based chimeric proteins were removed with 
cold EDTA and lysed at 5 x  106 ceUs/ml in lysis buffer (0.02 M Tris base, 
pH 8, 0.12 M NaC1, 0.2 mM EGTA, 0.2 mM NaFl, 0.2% DOC, 0.5% NP- 
40, 0.2 mM PMSF, 5 ixg/ml aprotinin). Lysates were boiled with an equal 
volume of sample buffer (50 mM Tris, pH 6.8, 2% SDS, 30% glycerol) and 
run on an 8-16% Tris-glycine mini gel (Novex, San Diego, CA) under 
nonreducing conditions. After transfer to nitrocellulose, CD4  was  de- 
tected with the anti-CD4 mAb No. 21 followed by HRP-conjugated goat 
anti-mouse IgG (Boehringer-Mannheim Biochemicals, Indianapolis, IN). 
Blots were developed using enhanced chemoluminescence (ECL; Amer- 
sham Corp.) and the intensity of CD4 bands quantitated by densitometry. 
Immunoprecipitation of 35S-cysteine  and  methionine-labeled viral pro- 
teins was performed and previously described (LaBranche et al., 1994). 
Immunoelectron Microscopy 
Immunoelectron microscopy of infected cells was performed as described 
previously (LaBranche et al., 1995). Cell suspensions in RPMI/10% FCS 
were incubated with anti-SU mAb (101.1)  for 30 min at 37~C. Cells were 
washed twice in ice-cold PBS and fixed with 2.5% glutaraldehyde in 0.1 M 
phosphate  buffer  for  60  min  at  room  temperature.  Fixed  cells  were 
washed twice in PBS and incubated with goat anti-mouse IgG-biotin fol- 
lowed by streptavidin-HRP. Cells were incubated in diaminobenzidine 
medium to develop the HRP reaction product, posffixed with osmium 
tetroxide,  and  embedded in  epoxy resin.  Thin  sections were  cut  and 
stained with lead. 
Viral Infectivity Assays 
Recombinant SIVs containing the NC-MAC envelope gene with either a 
Tyr or Cys at position 723 were produced in CEMx174 cells, as described 
(LaBranche et al., 1994). For infectivity assays, viruses were normalized 
for reverse transcriptase (RT) activity and inoculated onto Sup-T1 cells. 
The percentage of cells expressing viral p27g"g was evaluated by immuno- 
fluorescence microscopy on methanol and acetone fixed cells using the 
3A8 anti-p27  g"s mAb, and RT levels were determined on virions pelleted 
from culture supernatants (LaBranche et al., 1994). The stability of muta- 
tions in viruses during in vitro infection assays was determined by se- 
quence analysis of uncloned viral DNA amplified by PCR from genomic 
DNA, as described previously (LaBranche et al., 1994). 
Results 
Effects of  a Tyr-723 Mutation on the Distribution of 
Envelope Glycoproteins in SIV-infected Cells 
As previously described, a number of amino acid substitu- 
tions of Tyr-723 in viruses derived from the BK28 molecu- 
lar clone of SIV, or the analogous tyrosine in SIVmac239 
were  shown  to  up-regulate  the  expression  of envelope 
molecules on the cell surface without affecting the rate or 
efficiency of envelope protein synthesis (LaBranche ct al., 
1995).  To determine if mutations at this position altered 
the distribution of envelope glycoproteins in infected cells, 
Sup-T1 cells chronically infected by BK/NC-723Y or BK/ 
NC-723C were permeabilized and stained with the anti- 
TM mAb, 43.1. Within env, these viruses differed only by 
the presence of a Tyr or a Cys codon, respectively, at the 
position corresponding to amino acid 723 (LaBranche et 
al., 1995). On cells infected by BK/NC-723Y, the envelope 
glycoproteins were primarily detected in clustered intra- 
cellular structures and were minimally expressed on the 
cell surface (Fig. 1, A). In contrast, cells infected by BK/ 
NC-723C showed detectable but considerably reduced in- 
tracellular staining and prominent fluorescence at the cell 
surface (Fig. 1, B). FACS  ® analysis of nonpermeabilized 
cells using mAbs specific for either TM or SU envelope 
glycoproteins confirmed the  marked  increase in  surface 
envelope  glycoproteins  on  BK/NC-723C-infected  cells 
(Fig. 1, C). These findings indicated that on BK/NC-723Y- 
infected ceils, envelope glycoproteins were expressed pre- 
dominantly  in  intracellular  compartments,  and  that  the 
Y723C mutation caused these molecules to be redistrib- 
uted to the plasma membrane. Similar findings were noted 
when these same viruses infected two other CD4-positive 
lymphoid cell lines, HUT-78 and CEMx174 (not shown). 
Effects of the Y723C Mutation on 
Envelope Glycoprotein Distribution Using an env 
Expression Vector 
To determine if the difference in the distribution of enve- 
lope glycoproteins on infected cells could also be demon- 
strated in the absence of other viral proteins, env expres- 
sion was  evaluated in BHK-21  or HEp2 cells using the 
SFV replicon expression system (LiljestrSm and Garoff, 
1991; Paul et al., 1993; Olkkonen et al., 1994). In these ex- 
periments  the  CP-MAC  env  gene, which  contained the 
Y723C  mutation  (CP-MAC/723C),  was  compared to an 
identical  construct  that  lacked  this  mutation,  termed 
CP-MAC/723Y.  Experiments were also performed using 
the env gene of the parental SIV molecular clone, BK28 
termed BK28/723Y, which expressed a Tyr at position 723. 
The pSFV  1 vector containing the  cloned env genes was 
used to generate recombinant SFV virions to infect target 
cells and drive expression of the relevant SIV envelope 
protein. Expression of a functional SIV envelope protein 
at the cell surface was demonstrated by the ability of these 
cells to form syncytia when cocultured with appropriate 
CD4 + T-cell lines, Sup-T1 for CP-MAC-, and HUT-78 for 
BK28-derived envelope proteins (LaBranche et al., 1994, 
1995) (data not shown). SDS-PAGE analysis of [35S]me- 
thionine-labeled  cell  lysates  indicated  that  equivalent 
amounts  of  CP-MAC/723C,  CP-MAC/723Y  and  BK28/ 
723Y envelope protein were made in these SFV-infected 
cells (data not shown). 
The distribution of envelope glycoproteins was evalu- 
ated on intact and Triton X-100 permeabilized cells using 
an anti-SU mAb (101.1). As shown in Fig. 2, CP-MAC/ 
723C glycoproteins were expressed at high levels on the 
cell surface, similar to that seen for BK/NC-723C virus- 
infected cells (see above), and for Sup-T1 cells infected by 
the CP-MAC virus (LaBranche et al., 1994). In contrast, 
minimal surface staining was seen for the CP-MAC/723Y 
and the BK28/723Y envelope proteins, although intense 
intracellular staining was observed for all three viral enve- 
lope  proteins  after  permeabilization.  This  intracellular 
staining appeared to be associated with the endoplasmic 
reticulum and nuclear envelope and with cytoplasmic ve- 
sicular  structures.  Similar patterns  were observed when 
these  constructs  were  expressed  in  HEp2  cells  (not 
shown).  Thus, in cells expressing env  in  the  absence of 
other viral proteins, envelope glycoproteins containing a 
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by viruses with or without the Y723C mutation. Sup-T1 cells in- 
fected by BK/NC-723Y (A) or BK/NC-723C (B) were permeabi- 
lized and stained with the anti-TM mAb, 43.1. For BK/NC-723Y, 
envelope glycoproteins are predominantly distributed in intracel- 
lular sites, whereas for BK/NC-723C, envelope glycoproteins  are 
detectable primarily on the cell surface. (C) Surface expression of 
envelope glycoproteins  for the infected ceils shown in panels A 
and B is quantitated by FACS using anti-TM-  and anti-SU-spe- 
cific mAbs in comparison to uninfected  Sup-T1 cells. The murine 
mAb, P3x63, was used as a negative control. The mean channel of 
fluorescence intensity (MCF)  is shown. Cell populations analyzed 
were 100% infected as determined by p27  mg expression using im- 
munofluorescence  microscopy.  Reverse transcriptase activity of 
culture supernatants, as an indication  of the relative levels of vi- 
rus production, was comparable for each of the  infected  lines 
(494,992 cpm for BK/NC-723Y-  and 691,328 cpm for BK/NC- 
723C-infected cells). 
Tyr at position  723  are  minimally expressed on the  cell 
surface and are distributed predominantly in intracellular 
compartments.  As  with  the  SIV-infected cells,  a  Y723C 
mutation caused the envelope proteins to be partially re- 
distributed to the plasma membrane. 
Envelope Glycoproteins on Infected or env-expressing 
Cells Are Actively Endocytosed from the Cell Surface 
We had previously shown that the  increased surface ex- 
pression of envelope glycoproteins caused by the Y723C 
mutation could not be explained by alterations  in trans- 
port to the plasma membrane, shedding of envelope from 
infected cells, or differences in the incorporation of enve- 
lope molecules into virions (LaBranche et al., 1994,  1995). 
To determine if the low surface and high intracellular lev- 
els of envelope molecules on BK/NC-723Y-infected cells 
resulted  from  glycoproteins  that  were  transiently  ex- 
pressed  on  the  cell  surface  and  then  endocytosed,  cells 
were incubated in the presence of an anti-SU mAb (101.1) 
at 37°C for varying periods of time and then fixed and per- 
meabilized to detect  internalized  antibody.  As shown in 
Fig. 3, despite the low steady state level of surface enve- 
lope glycoproteins (A),  intracellular  anti-SU mAb could 
clearly be shown as early as 15 min (B), and by 60 rain (D) 
was densely clustered in intracellular vesicles. Similar find- 
ings  were  observed  when  these  experiments  were  per- 
formed with 15 ixg/ml of a Fab fragment of the 101.1 mAb, 
indicating that the effect was not due to crosslinking of en- 
velope molecules on the cell surface (not shown). No up- 
take was seen for an isotype matched control mAb (not 
shown).  Endocytosis of envelope molecules was also ob- 
served  when  identical  experiments  were  performed  on 
Sup-T1  cells  infected  by  BK/NC-723C  (not  shown),  al- 
though these experiments could not determine if quantita- 
tive differences in endocytosis existed between these two 
viruses (see below). 
To determine if envelope glycoproteins expressed in the 
absence of other viral proteins were also internalized, sim- 
ilar experiments were performed using the SFV constructs 
described above. BHK-21 cells expressing the  CP-MAC/ 
723C,  CP-MAC/723Y  or  BK28/723Y  envelope  proteins 
were incubated for 2 h  at 37°C with mAb 101.1,  and then 
fixed and stained for immunofluorescence microscopy. On 
cells expressing CP-MAC/723C,  cell surface staining was 
seen on >90% of cells, while on cells expressing CP-MAC/ 
723Y or BK28/723Y little if any cell surface staining was 
observed (Fig. 4 A, top). However, when cells were perme- 
abilized  before  staining,  prominent  intracellular  fluores- 
cence  of  internalized  antibody  was  seen  for  CP-MAC/ 
Sauter et al. SIV Transmembrane Protein Endocytosis Signal  799 Figure 2.  Effects of the Y723C mutation on the distribution of envelope glycoproteins in cells expressing env. BHK-21 cells expressing 
SIV envelope glycoproteins from recombinant SFV vectors were stained with anti-SU mAb (101.1), as described in Materials and Meth- 
ods, either intact (top) or after permeabilization (bottom) with Triton X-100. Env genes included CP-MAC, which contained a Y723C 
mutation (CP-MAC/723C), CP-MAC in which the 723-Cys was changed to a Tyr (CP-MAC/723Y), and BK28, which also contained a 
Tyr at position 723 (BK28/723Y). Although all env proteins could be detected intracellularly (Bottom) only CP-MAC/723C env was ex- 
pressed at high levels on the cell surface. 
723Y- and BK28/723Y-env expressing cells (Fig. 4 A, bot- 
tom). Intracellular staining was also evident for CP-MAC/ 
723C-expressing  cells,  although  this  pattern  was  some- 
what masked by the bright surface staining that was also 
present.  When  identical experiments  were  performed  in 
HEp2  cells and the  anti-SU mAb was stripped from the 
cell surface with  acid treatment  prior to  staining,  a  less 
prominent intracellular fluorescence pattern was seen for 
CP-MAC/723C-compared  to  CP-MAC/723Y-expressing 
cells (Fig. 4  B).  Identical results were obtained when  ex- 
Figure 3.  Endocytosis of envelope glycoproteins on SIV-infected cells. Sup-T1 cells chronically infected with BK/NC-723Y were incu- 
bated with anti-SU mAb for the indicated times at 37°C and fixed in methanol and acetone. Internalized antibody was detected with a 
FITC-labeled secondary antibody. As shown, intracellular antibody could be detected at 15 min in a vesicular pattern, which increased 
in intensity at the 30- and 60-min time points. 
The Journal  of Cell Biology,  Volume 132, 1996  800 periments were performed using a mAb reactive with the 
TM  component  of  the  envelope  protein  (43.1)  (not 
shown). These results indicated that the  CP-MAC/723Y 
and BK/28 envelope proteins, both of which contain a ty- 
rosine at position 723, are transported to the cell surface 
and are then rapidly internalized resulting in a low steady 
state level of expression on the plasma membrane. In con- 
trast, the CP-MAC envelope protein is transported to the 
cell surface where it accumulates. Together, these findings 
suggested that differences in surface expression of enve- 
lope glycoproteins caused by the Y723C mutation on SIV 
infected as well as env-expressing cells could have resulted 
from differences in the  kinetics and/or efficiency of en- 
docytosis of these molecules from the plasma membrane. 
Endocytosis of SIV Envelope Glycoproteins on Infected 
Cells Is Mediated by Coated Pits 
The above findings demonstrated that in addition to being 
incorporated into viral particles,  envelope glycoproteins 
expressed on the cell surface can also be actively endocy- 
tosed. Similar findings have been noted for the simian vi- 
rus-5 (Ng et al., 1989) and Rous sarcoma virus (Johnston 
et  al.,  1995)  envelope  glycoproteins.  To  determine  the 
mechanism by which the SIV proteins were internalized, 
immunoelectron microscopy was performed. Sup-T1 cells 
chronically infected with SIVs that contained either a Tyr 
or a Cys at position 723 were incubated for 30 min at 37°C 
with anti-SU mAb (101.1) and processed for immunoelec- 
tron microscopy using an HRP-labeled anti-mouse Ig, as 
described previously (LaBranche et al., 1995). For cells in- 
fected by SIVs  with  a  723-Tyr, low-magnification views 
showed that  envelope glycoproteins were minimally ex- 
pressed on the cell surface (Fig. 5, a), a result consistent 
with data shown in Fig.  1 and our previous observations 
(LaBranche et al., 1995). However, although the vast ma- 
jority of the plasma  membrane on these cells was unla- 
beled, a careful analysis of multiple fields at higher magni- 
fications revealed an  association  of envelope molecules 
with invaginations on the plasma membrane that resem- 
bled clathrin-coated pits (Fig. 5, b--e). Given the reduced 
amount of envelope glycoprotein expressed on the surface 
of these cells and the fact that coated pits typically make 
up 1-2% of the plasma membrane (Anderson et al., 1977; 
Pelchen-Matthews et al., 1991), this association was strik- 
ing.  Similar findings were seen on cells infected by NC- 
MAC, BK/NC-723Y, and BK28, all of which contained a 
Tyr at position 723. 
Immunoelectron  microscopy  was  also  performed  on 
cells infected with viruses that contained a Y723C muta- 
tion. In marked contrast to cells infected by viruses with a 
723-Tyr, an  analysis  of numerous  cells showed labeling 
over the entire plasma membrane, as previously reported 
(LaBranche et al., 1995) (Fig. 5, f). At higher magnifica- 
tions, labeled pits  could also  be demonstrated  on these 
cells (Fig. 5, g-i). However, this finding was not surprising 
in view of the diffuse distribution of envelope glycopro- 
teins on the cell surface. Similar findings were seen for all 
viruses  that  contained  the  Y723C  mutation  including 
CP-MAC,  BK/NC-723C, and BIrU723C, and identical re- 
sults were observed in chronically infected HUT-78 and 
CEMx174 cells (not shown). 
These results indicated that SIV envelope glycoproteins 
containing a 723-Tyr are endocytosed, at least in part, by 
coated pits. This finding raised the possibility that the en- 
velope protein could contain a Tyr-dependent internaliza- 
tion signal similar to those identified in the cytoplasmic 
domains of a  number of cellular membrane proteins, in- 
cluding the low density lipoprotein receptor (LDLr), the 
transferrin  receptor,  and  lysosomal  acid  phosphatase 
(Vaux, 1992; Trowbridge et al., 1993). 
The Cytoplasmic Domain of SIV TM 
Mediates Endocytosis When Transferred to a 
Heterologous Molecule 
To  determine  if a  functional  internalization  signal  was 
present  in  the  SIV  TM,  chimeric  molecules  were  con- 
structed that contained the CD4 external and membrane 
spanning domains and the TM cytoplasmic tail from BK28 
(Fig.  6).  As  with  other  CD4-based  chimeric molecules, 
Val-395/Arg-396  of the  CD4  sequence was  used  as  the 
junction site between the membrane spanning and the cy- 
toplasmic domains (Littman et al., 1988; Bedinger et al., 
1988; Aiken et al., 1994; Anderson et al., 1994). Chimeras 
were also generated in which Tyr-723 in the SIV TM tail 
was changed to a Cys, Ala, Ser, Ile, or Phe. Control con- 
structs included a chimeric molecule containing the CD4 
external and membrane spanning domains and the entire 
LDLr cytoplasmic domain (designated CD4/LDLr) and a 
CD4 molecule containing only a 4-amino acid cytoplasmic 
domain (designated CD4/tail-minus)  (Fig. 6).  Constructs 
were cloned into the pMV-6 retroviral vector and stable 
lines of HeLa cells expressing these molecules were de- 
rived (see Materials and Methods). All constructs were ex- 
pressed at the cell surface as detected using an mSI-labeled 
anti-CD4 binding assay and FACS  ® analysis (Table I, see 
below). 
Endocytosis of CD4/SIV TM chimeric molecules was 
evaluated using an lz~I-labeled anti-CD4 mAb in an acid 
elution protocol, (see Materials and Methods). As shown 
(Fig. 7 A  and Table II) the CD4/LDLr chimera was en- 
docytosed rapidly with ~60% of the cell-associated mAb 
internalized within 2 min of warm-up and 81% intracellu- 
lar after 60 min. The plateau in the curves shown in Fig. 7 
has been noted in other studies of CD4 endocytosis and 
reflects the steady state equilibrium between internaliza- 
tion and recycling to the cell surface (Pelchen-Matthews et 
al., 1989). This result was in marked contrast to the CD4/ 
tail-minus construct, which was internalized at 0.7%/min 
with only 11% intracellular at 60 min. These studies indi- 
cated that the internalization signal present in the LDLr 
cytoplasmic domain was able to function efficiently when 
transferred to CD4. 
When identical assays were performed on the CD4/SIV 
TM chimeras, the CD4 construct containing the BK28 TM 
cytoplasmic domain (CD4/SIV 723-Tyr) was endocytosed 
at 4.2%/min with 51%  intraceUular at 60 min. Although 
slower than the CD4/LDLr chimera, the CD4/SIV 723-Tyr 
was internalized three to four times faster than constructs 
containing mutations at position 723, including Phe-723. 
Significantly, all these mutant constructs showed slightly 
elevated rates of endocytosis over the CD4-tail minus con- 
struct suggesting some residual endocytosis signaling in- 
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lope glycoproteins in cells tran- 
siently  expressing  the  viral  env 
gene. (A) BHK-21 cells express- 
ing the viral env genes described 
in Fig. 2 were incubated at 37°C 
for  2  h  with  anti-SU  mAb 
(101.1)  and  washed.  The  cells 
were  stained  either  intact,  or 
after  permeabilization,  with 
rhodamine-conjugated  anti- 
mouse Ig. (B) A  similar experi- 
ment  is  shown  for  HEp2  cells 
expressing  the  CP-MAC/723C 
and  CP-MAC/723Y  env  genes. 
However,  in  this  assay,  cells 
were  incubated  with  acid  me- 
dium to remove cell surface anti- 
body prior to fixation. Although 
intraceUular  antibody  could  be 
detected for both envelope pro- 
teins,  more  intracellular  stain- 
ing  was  seen  for  CP-MAC/ 
723Y-  than 'for CP-MAC/723C- 
env expressing cells. 
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These studies demonstrated that the SlV TM cytoplasmic 
tail contained an internalization signal that could mediate 
endocytosis of a heterologous molecule and that the effi- 
ciency of this signal was dependent on the presence of a ty- 
rosine at position 723. 
Increasing the Distance of Tyr-723 from the 
Membrane Spanning Domain Improves the Efficiency 
of the SIV Endocytosis Signal 
As  described above, the BK28 TM cytoplasmic domain 
was able to direct endocytosis of CD4. However in these 
chimeric proteins, mutations that disrupted this endocyto- 
sis signal failed to produce differences in the expression of 
the chimeras on the cell surface (Table I). This result was 
in contrast to our findings for envelope proteins produced 
by infectious viruses or the SFV expression system. Stud- 
ies of the transferrin receptor have indicated that the effi- 
ciency of the YTRF internalization signal is influenced by 
its distance from membrane spanning domain, with at least 
seven amino acids required for rapid endocytosis (Collawn 
et al.,  1990). Because in the CD4/SIV-TM chimeras, Tyr- 
723 was predicted to be six amino acids from the mem- 
brane spanning domain we considered the possibility that 
the internalization signal at Tyr-723 might function ineffi- 
ciently in this setting. Moreover, the junction between the 
SIV membrane spanning and cytoplasmic domains is not 
well-defined, raising the possibility that Tyr-723 could be 
located further than six amino acids from the membrane in 
the  viral  protein  (see  Discussion).  We  therefore  con- 
structed another set of chimeric molecules in which an ad- 
ditional four amino acids of the CD4 cytoplasmic tail were 
included  (Fig.  6).  Constructs were made  that  contained 
SIV TM tails with a Tyr or Cys at SIV position 723, desig- 
nated  CD4/spacer-723Y  and  CD4/spacer-723C,  respec- 
tively. These molecules were introduced into pMV-6 and 
stably expressed in HeLa cells, as described above. 
In contrast to the previous chimeras, and similar to the 
intact viral envelope protein,  the  CD4/spacer-723Y  chi- 
mera was expressed at a low level on the cell surface (see 
below). Moreover, as shown in Fig. 7 B, this chimera was 
internalized three- to fivefold faster than  the  CD4/SIV- 
723Y  chimera  (18%/min  with  77%  internal  at  60  min), 
demonstrating  that  the  introduction  of a  4-amino  acid 
spacer between the transmembrane domain and Tyr-723 
improved the efficiency of the endocytosis signal  (Table 
II).  Importantly,  a  Y723C  mutation  in  the  CD4/spacer- 
723C  molecule markedly reduced endocytosis to  a  rate 
comparable to that of other chimeras with mutations at 
this position (1.4%/min). These results indicated that the 
internalization motif identified in the SIV TM cytoplasmic 
tail could function almost as efficiently as the LDLr signal 
provided it was positioned at a sufficient distance from the 
membrane spanning domain. 
Surface and IntraceUular Expression of CD41SIV 
Chimeric Molecules 
Additional studies were performed to determine if the dif- 
ferences in  endocytosis rates  of CD4/SIV-TM  chimeric 
molecules expressed on HeLa cells correlated with differ- 
ences in the distribution of these molecules on the cell sur- 
face  and  at  intracellular  sites.  The  expression  of CD4/ 
spacer-723Y, CD4/spacer-723C and CD4/LDLr chimeras 
was evaluated on permeabilized cells by immunofluores- 
cence  microscopy.  As  shown  in  Fig.  8  for  both  CD4/ 
spacer-723Y (A) and the CD4/LDLr (C), intense intracel- 
lular staining was apparent with a prominent vesicular pat- 
tern and with little staining seen on the cell surface. In con- 
trast, for CD4/spacer-723C (B) a diffuse pattern of surface 
fluorescence was seen. Similar results were observed for 
several clones of each cell line (not shown). When the sur- 
face expression on these chimeras was quantitated using 
an  lZSI-labeled  anti-CD4  mAb  binding assay or FACS  ® 
analysis,  a  three- to fourfold increase was  observed for 
CD4/spacer-723C  (Table I). This result was  particularly 
impressive in view of the finding that the total level of chi- 
meric proteins in whole cell lysates was ~10-fold less for 
the CD4/spacer-723C compared to the CD4/spacer-723Y 
chimera (Table I). These findings demonstrated that,  as 
with the intact viral envelope protein, a Y723C mutation 
caused this CD4/SIV-TM chimera to be redistributed from 
intracellular compartments to the cell surface. 
Biological Effects of  a Tyr-723 Mutation 
on Infectious Viruses 
Because the expression of HIV and SIV envelope glyco- 
proteins has been shown to correlate with viraUy induced 
cytopathie effects (Lifson et al., 1986; Bosch et al., 1989; 
Steffy et  al.,  1992),  we  evaluated  the  biological conse- 
quences of a mutation at Tyr-723 on viral infection of a hu- 
man T cell line. For this experiment we used recombinant 
SIVs containing the envelope glycoprotein of NC-MAC, a 
variant SIV that  has  been shown to infect Sup-T1  cells 
(LaBranche et al., 1994). BK/NC-723Y and BK/NC-723C, 
which contained either a Tyr or Cys, respectively, at posi- 
tion 723 in the TM cytoplasmic domain (LaBranche et al., 
1995) were inoculated onto Sup-T1 cells, and the kinetics 
of viral infection were evaluated by serially determining 
the percentage of cells expressing viral antigens and level 
of reverse transcriptase activity in culture supernatants. As 
shown in Fig. 9, the replication of BK/NC-723Y was mark- 
edly attenuated in Sup-T1 cells and only 15-20% of cells 
were positive for p27  gag even after 70 d (a, open squares, 
open diamonds). This retarded infection is similar to that 
initally described for NC-MAC infection of Sup-T1 cells 
(LaBranche et al., 1994).  In contrast, while BK/NC-723C 
exhibited a similar late onset of infection, once infection 
was initiated, virus spread through the culture was rapid 
with >90% of cells expressing viral antigens by day 60 (a, 
closed squares). A  10-fold dilution  in  the  inoculum  re- 
suited in a further delay in the onset of infection, but was 
followed by a similar rapid spread once the infection was 
detectable (a, closed diamonds). This difference in infec- 
tion kinetics was also reflected in RT levels with BK/NC- 
723C showing a more rapid increase as well as a five- to 
sixfold higher level compared to BK/NC-723Y (Fig. 9 b). 
Sequence analysis  of uncloned viral DNA  amplified by 
PCR  from infected cultures demonstrated that no addi- 
tional mutations in the viral env gene had occurred for ei- 
ther BK/NC-723Y or BK/NC-723C during the course of 
this infection (not shown). 
Sauter et al. SIV Transmembrane Protein Endocytosis Signal  803 Figure 5.  Immunoelectron microscopy of surface envelope glycoprotein distribution on SIV-infected Sup-T1 cells. Sup-T1 cells chroni- 
cally infected by SIVs containing a Tyr (a--e) or Cys (f-i) at position 723 in the TM cytoplasmic tail were labeled with an anti-SU mAb 
(101.1) and stained for immunoelectron microscopy with HRP-conjugated  anti-mouse Ig. Viruses were NC-MAC (a--c), BK/NC-723Y 
(d and e), CP-MAC (f-h) and BK/NC-723C (i). A low-magnification view of NC-MAC-infected cells (a) shows the paucity of envelope 
glycoprotein distributed on the cell surface, while intermediate (b) and high magnification views (c-e) show localization of labeled enve- 
lope molecules in coated pits. For viruses with a 723-Cys, a low-magnification view (f) shows envelope glyeoproteins diffusely distrib- 
uted over the entire plasma membrane. Intermediate and high magnification views of other cells also show the presence of detectable 
envelope molecules both in and around coated pits (g-/). Arrows in b and g show the presence of labeled envelope glycoproteins in pits 
at intermediate  and low magnification views. Bars: (a and 1) 2 Ixm; (b and g) 0.2 i~m; (c-e, h, and i) 0.2 tLm. 
In addition to a  more rapid spread of infection, cyto- 
pathic effects were also striking in BK/NC-723C-infected 
cultures, as seen by the presence of large syncytia (Fig. 10 B). 
In contrast, for BK/NC-723Y no syncytia were seen at any 
time during the course of the infection, despite the pres- 
ence of multiple single antigen-positive cells (Fig. 10 A). 
These results demonstrate that the loss of the internaliza- 
tion signal at Tyr-723 for this  SlV and  the resulting in- 
crease in envelope glycoproteins on the surface of infected 
cells significantly altered the biological properties of the 
virus in vitro. 
Discussion 
The cytoplasmic domains of viral envelope glycoproteins 
have been shown to play critical roles in viral pathogenesis 
(Dubay et al., 1992; Gabuzda et al., 1992; Gray and Roth, 
1993;  Johnston et al.,  1993;  Yu et al.,  1993;  Zhao et al., 
1994). These domains may interact with the core proteins 
to facilitate the  incorporation of envelope proteins into 
virions during viral assembly and may also modulate func- 
tional properties of the envelope proteins (Gonzalez et al., 
1993;  Yu et al.,  1993;  Zhao et al.,  1994;  Bugelski et al., 
1995). In addition, these domains likely interact with cellu- 
lar factors that can affect envelope glycoprotein transport, 
sorting and mobility (Doyle et al., 1985; Haffar et al., 1990; 
Johnston et al., 1993; Lydy and Compans, 1993; Lodge et 
al., 1994). For HIV-1 and SIV, a number of studies have 
suggested that the TM cytoplasmic domain may also affect 
the level of envelope protein expression on the cell surface 
(Johnston et al., 1993; LaBranche et al., 1995; Salzwedel et 
al.,  1993;  Weiss  and  White,  1993;  Zingier and  Littman, 
1993), although the mechanism for this effect remains un- 
clear. We previously found that the presence of a  Tyr at 
position  723  in  the  SIV TM cytoplasmic domain corre- 
sponds to a  low level of surface envelope protein on in- 
fected cells (LaBranche et al., 1995). In the present study, 
we show that this residue is part of a signal that mediates 
rapid and efficient endocytosis of envelope glycoproteins 
from the plasma membrane and that contributes to the cy- 
topathic potential of the virus. The activity of this internal- 
ization signal was shown on SIV-infected cells and on cells 
The Journal of Cell Biology, Volume 132, 1996  804 Figure 6.  Construction of CD4-based chimeric molecules. Amino 
acid sequences  are shown above the horizontal line for the puta- 
tive junctions between the membrane spanning  domains and cy- 
toplasmic domains for the BK28 SIV TM, the LDLr, and CD4. 
Tyr residues implicated  as contributing  to endocytosis signals for 
SIV-TM and the LDLr (Davis et al., 1987) are indicated  at posi- 
tions  723 and 807, respectively.  A  series  of chimeric  molecules 
were constructed as described in Materials and Methods and are 
shown below the horizontal line. These include: (a) CD4/SlV-TM 
constructs  in which the cytoplasmic domain consisted of only the 
18-amino acid SIV-TM cytoplasmic tail, (b) CD4/spacer SIV-TM 
constructs in which the first four amino acids from the CD4 cyto- 
plasmic tail were included, and (c) CD4/LDLr in which the entire 
cytoplasmic domain was derived from the LDLr. For the CD4/ 
SIV-TM and CD4/spacer  SIV-TM chimeras, constructs were pro- 
duced as indicated  that included  single amino acid substitutions 
of Tyr-723. For each chimera, the junction between CD4 and the 
SIV-TM or LDLr cytoplasmic  domain is indicated.  A  CD4-tail 
minus construct is also shown (d), which contained a prematurely 
truncated cytoplasmic domain. 
expressing the viral env gene in the absence of other viral 
proteins. By immunoelectron microscopy, envelope glyco- 
proteins containing  the  signal were preferentially associ- 
ated  with  endocytic  structures  that  resembled  clathrin- 
coated pits, and mutations of Tyr-723 profoundly altered 
the  distribution  of  the  envelope  protein,  causing  these 
molecules to be dispersed  over the  entire  plasma mem- 
brane. The presence of an endocytosis motif was clearly 
demonstrated  by the  ability of the  SIV TM cytoplasmic 
tail to mediate internalization of a heterologous molecule, 
CD4, when used to replace the CD4 cytoplasmic domain. 
A  number of amino acid substitutions at Tyr-723 in these 
chimeric  proteins  disrupted  the  signal  and  reduced  en- 
docytosis  to  a  level  approaching that  of a  tail-less  CD4 
molecule. As seen for the intact envelope glycoprotein, a 
Y723C mutation in the CD4/spacer SIV-TM chimera also 
caused this molecule to be redistributed from intracellular 
sites to the plasma membrane. Finally, mutation of the pu- 
tative internalization motif in an infectious virus had pro- 
found effects on the kinetics of viral infection and on cyto- 
pathic properties of the virus during replication in vitro. 
The  demonstration  of an  endocytosis  motif in  this  viral 
glycoprotein is highly reminiscent of early studies of the 
"JD" mutation in the human LDLr, where a  Tyr to Cys 
mutation  at  position  807  in  the  cytoplasmic domain  in- 
creased receptor expression on the cell surface by reduc- 
ing  its  efficiency of internalization  (Davis  et  al.,  1986). 
These results demonstrate the first example of a similar in- 
ternalization  motif being used by a  virus to regulate the 
level of envelope proteins on the cell surface. 
For a  number of cell surface transmembrane proteins, 
clathrin-dependent endocytosis can be mediated by a cyto- 
plasmic domain structural motif that includes one or more 
aromatic amino acids, generally a tyrosine (Trowbridge et 
al., 1993; Vaux, 1992). For the LDLr, transferrin receptor, 
and lysosomal acid phosphatase, this motif has been sug- 
gested to resemble a reverse 13 turn in which the Tyr plays 
a  critical role as an electron donor (Collawn et al., 1990; 
Bansal and Gierasch, 1991; Eberle et al., 1991). Moreover, 
mutations predicted to disrupt this turn structure reduce 
the endocytosis rates for these molecules and, as a conse- 
quence, increase their steady state expression on the cell 
surface (Davis et al., 1986; Lazarovits and Roth, 1988; Pe- 
ters et al., 1990). Although internalization motifs on cellu- 
lar molecules appear to share a  common structure rather 
than sequence, broad consensus sequences have been pro- 
posed to involve either a 4-amino acid motif with an aro- 
matic  amino  acid  in  the  first  position  and  an  aromatic/ 
large hydrophobic amino acid in the fourth position (Aro- 
X-X-Aro/Large  hydrophobic)  or  a  6-amino  acid  motif 
with aromatic amino acids in the first and sixth positions 
(Aro-X-X-X-X-Aro) (Trowbridge et al., 1993). As shown 
in  Fig.  6,  the  YRPV  sequence  in  the  SlV-TM  fits  the 
former of these  patterns  suggesting  that  amino acids  on 
the carboxy terminal side of Tyr-723 could be involved in 
forming a turn. However, molecular modeling of the SIV 
TM cytoplasmic domain has indicated that the sequence, 
RQGY  (amino  acids  720-723)  has  a  high  potential  to 
adopt  a  13  turn  conformation,  suggesting  that  residues 
NH2-terminal to Tyr-723 might be involved in producing 
the  signal  (Laurence  Pearl,  unpublished  observations). 
Further mutagenesis will be required to define the struc- 
ture  of the  SIV-TM endocytosis  motif.  Interestingly, all 
isolates of HIV-1 exhibit a  striking similarity to SIVs in 
this  region  of TM,  with  an  RQGY  consensus  sequence 
proximal to the analogous Tyr (Myers et al., 1993). More- 
over, the following YSPL sequence on the carboxyl side of 
this Tyr is similar to the sequence YQPL, which has been 
shown  to  contribute  to  an  internalization  signal  for  the 
CD3  ~/  and  ~  chains  (Letourneur  and  Klausner,  1992). 
Therefore, it is plausible that a Tyr-dependent endocytosis 
signal may also exist for HIV-1. Indeed, recent findings by 
Rowell et al. for HIV-1 envelope glycoproteins expressed 
by vaccinia have implicated the analogous Tyr at position 
707 in directing loss of envelope glycoprotein from the cell 
surface, presumably by affecting its rate of internalization 
(Rowell et al., 1995). 
Tyr-dependent  internalization  signals  in  cellular  pro- 
teins are functional when transferred to heterologous mol- 
ecules, where their activity has been shown to be largely 
independent  of position and  orientation  (Collawn  et al., 
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Surfacelevel*  Total levels  ~ 
FACS  ®¢  Densitometry 
1251_antibody binding  (anti-CD4 mAb)  units 
fmol boumt/l O  ~  cells 
CD4tSIV-TM chimeras 
CD4/SIV-TM (723 Y)  167  317  3,657 
CD4/SIV-TM (723 C)  214  412  5,042 
CD4/SIV-TM (723 S)  168  517  4.454 
CD4/SIV-TM (723 i)  222  357  3,906 
CD4/SIV-TM (723 F)  338  320  3,692 
CD4/SIV-TM (723 A)  317  838  4,034 
CD4/spacer-TM chimeras 
CD4/spaeer SIV-TM (723 Y)  35  16  2,129 
CD4/spacer SIV-TM (723 C)  115  51  262 
CD4/LDLr chimera  20  28  354 
CD4/tail-minus  484  275  4,565 
HeLa Control  I  ND**  1  ND 
*HeLa cells stably expressing the CD4-based chimeric molecules indicated (see Fig. 6) were evaluated for surface expression using either an l~l-labeled anfi-CD4 mAb or FACS  ® 
analysis. For the iodinated antibody assay, numbers reflect surface binding at the kD concentration of antibody (0.3-0.4 mM) and therefore represent approximately half the num- 
ber of CD4 chimeric molecules expressed. 
*Numbers for FACS  ®  analysis indicated mean channel fluorescence  intensity units using an anti-CD4 mAb. For each determination shown the background results for an isotype 
matched negative control mAb were subtracted. 
t Total expression was evaluated in Western blots of whole cell lysates using an anti-CIM mAb. Numbers indicate values obtained by densitometric scans of autoradiographs. 
IUninfected HeLa cells were used as a control. 
**Not determined. 
1990; Collawn et al.,  1991; Jadot et al., 1992).  However, 
studies of the transferrin receptor YTRF signal have indi- 
cated that a critical distance of seven or more residues is 
required between the Tyr and the membrane spanning do- 
main for optimal function (Collawn et al.,  1990).  As we 
demonstrated,  CD4/SIV-TM  chimeras  in  which Tyr-723 
was located six amino acids from the predicted membrane 
spanning domain  were  endocytosed  less  efficiently  than 
similar constructs that included the first four amino acids 
of the CD4  cytoplasmic  tail  (Fig.  7). The more  efficient 
function of the viral endocytosis signal in the artificial set- 
Table II. Endocytosis  Rates of CD4/SIV-TM Chimeric 
Molecules* 
Amino acid 
at SIV position  No. of 
Chimera type  No. 723  assays  Rate*  Percent internal  ~ 
%/min  60 min 
CD4/SIV-TM  Tyr  14  4.2 ---  1.8  51  -  3 
Cys  8  1.1  ±  0.5  21  ±  2 
Phe  5  1.5 ±  0.4  22 ±  2 
Ala  4  1.5 ±  0.6  18 ±  3 
Ser  2  1.7 -  1.1  21  ±  0.4 
Ile  2  1.5 ±  0.6  21  ±  0.3 
CD4/spacer SIV-TM  Tyr  4  17.7  ±  6.9  77 ±  11 
Cys  4  1.4 ±  0.6  22 ±  1 
CD4/LDLr  -  4  31.0 -  5.0  81  ±  11 
CD4/tail-minus  -  6  0.7 ±  0.2  11  ±  1 
*Endocytosis  of the CD4-based  chimeras indicated  and diagrammed in Fig. 6 was 
evaluated on HeLa cells stably expressing  these molecules using an 1251-labeled anti- 
CD4 mAb, as previously described (Pelchen-Mattbews  et al., 1989), and summarized 
in Materials and Methods. For constructs containing the SIV-TM cytoplasmic  domain, 
the amino acid at SIV position 723 is indicated. 
*Endocytosis rates were determined by plotting the acid-resistant counts as a percent- 
age of the total cell-associated  counts for each time point and calculating  the rate of 
uptake over the In'st 5 min of the assay (± SEM). 
0Numbers indicate the percentage of anti-CD4 mAb initially bound that was internal- 
ized (i.e., resistant to acid elution) after 60 rain (± SEM). 
ting of this chimeric protein raises some question concern- 
ing the assignment of the membrane spanning domain/cy- 
toplasmic  tail junction for the native SIV TM  molecule. 
Hunter et al. have recently proposed that the beginning of 
the SIV TM cytoplasmic domain may be proximal to that 
shown in Fig. 6, since viral proteins containing premature 
termination codons at Gin-714 were still anchored in the 
plasma membrane (Hunter, E., personal communication). 
Thus, it is possible that Tyr-723 is located more than six 
amino acids from the membrane spanning domain in the 
viral  glycoprotein,  enabling  the  internalization  motif  to 
function optimally in its natural context. 
It  is  important  to recognize  that the  SIV  used  in  the 
present  study contained  a  TM  cytoplasmic  domain  that 
was  prematurely  truncated,  a  consequence  of  its  initial 
propagation  in  human  cells  (Kodama  et  al.,  1989). 
Whereas HIV and SIV in their natural host cells maintain 
cytoplasmic tails of approximately 150-165 amino acids, in 
human cell  lines  SIVs  characteristically  develop  prema- 
ture  stop  codons  18-24  amino  acids  from  the  predicted 
membrane spanning domain (Hirsch et al., 1989; Kodama 
et al., 1989). It will be of interest to evaluate the function 
of the endocytosis motif we have identified in the context 
of a full-length cytoplasmic domain. We  have previously 
shown that mutations of the analogous Tyr in an SIV with 
a  full-length TM  up-regulated the level  of surface  enve- 
lope glycoprotein on infected cells, although, interestingly, 
this effect was appreciably smaller than that seen for SIVs 
with a prematurely truncated TM (LaBranche et al., 1995). 
This  finding  could  be  explained  by  determinants  in  the 
full-length tail that modulate the function of the endocyto- 
sis motif at Tyr-723 or by the presence of additional sort- 
ing signals distal to the premature stop codon. Indeed, the 
observation that SIVs with premature termination codons 
in their cytoplasmic tails express increased amounts of sur- 
face envelope glycoprotein (Johnston et al., 1993; Zingler 
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Figure  7.  Endocytosis of CD4/SIV-TM chimeric molecules.  En- 
docytosis  rates  of CD4-based constructs  that  were  stably ex- 
pressed in HeLa cells were quantitated using an acid-elution  en- 
docytosis  assay previously described  (Pelchen-Matthews  et al., 
1989). Each panel shows the acid-resistant  (internal)  1251 counts 
as a percentage of the total cell-associated  counts for each time 
point. A shows results for CD4/SIV-TM chimeras in which the cy- 
toplasmic domain consisted  entirely of the SIV TM tail (Fig. 6). 
Results are compared to the CD4/LDLr and CD4-tail minus con- 
structs. As shown, the SIV-TM domain in the CD4/SIV-TM con- 
struct, which contains a 723-Tyr, is endocytosed rapidly, although 
at a rate considerably slower than that of a similar construct con- 
taining the LDLr tail. All amino acid substitutions  at position 723 
including a Phe, reduced endocytosis to rates approaching that of 
the tail-minus CD4. B shows a similar study for chimeras that in- 
cluded the first four amino acids of the CD4 cytoplasmic domain. 
As shown, the construct  containing the SIV Tyr-723 was endocy- 
tosed at a rate similar to the CD4/LDLr chimera. Endocytosis  of 
the chimera containing  a Tyr to Cys substitution  at position 723 
was markedly impaired. 
and Littman, 1993) could be explained by a loss of addi- 
tional internalization or sorting motifs in the distal region 
of  the  tail.  Multiple  sorting  signals  have  been  demon- 
strated in the cytoplasmic domains of several cellular mol- 
ecules  including  the  LDLr  (Matter  et  al.,  1993),  cation- 
dependent mannose-6-phosphate receptor (Johnson et al., 
1990), asialoglycoprotein receptor (Fuhrer et al., 1991), in- 
sulin  receptor  (Rajagopalan  et  al.,  1991),  CD3  ~/  and 
chains  (Letourneur  and  Klausner,  1992),  and  the  MHC 
class II invariant chain (Odorizzi et al., 1994). The SIV and 
HIV TM  cytoplasmic domains  do  exhibit  a  number  of 
other conserved Tyr residues  as well as pairs of Leu/Ile 
residues, which have also been implicated as internaliza- 
tion  and/or  sorting signals for several cellular molecules 
(Shin et al., 1991; Letourneur and Klausner, 1992; Corvera 
et al,,  1994;  Odorizzi et al.,  1994).  In addition,  although 
Tyr-723 mutations in the CD4tSIV-TM chimeric proteins 
reduced  internalization,  their  rates  of endocytosis  were 
still greater than that of a  CD4 construct lacking a  cyto- 
plasmic domain  (Fig.  7).  This finding  suggests that even 
when Tyr-723 is mutated, there is still some residual inter- 
nalization signal in a prematurely truncated TM. The as- 
says we have developed to quantitate endocytosis in these 
viral molecules will be valuable tools to address these is- 
sues. 
These  findings  indicate  that  on  SIV-infected  or  env- 
expressing cells, viral glycoproteins on the plasma mem- 
brane may be targeted either to budding virions or to en- 
docytic vesicles.  It remains to be determined  what viral 
and cellular factors are involved in regulating trafficking 
along these  two  distinct  pathways. By analogy with  the 
LDL, asialoglycoprotein and epidermal growth factor re- 
ceptors (Pearse,  1988;  Glickman et al.,  1989;  Pearse and 
Robinson, 1990; Beltzer and Spiess, 1991; Sorkin and Car- 
penter, 1993;  Lamaze and Schmid, 1995), it is likely that 
internalization of the SIV TM glycoprotein is mediated by 
an interaction with clathrin adaptor molecules. These pro- 
tein complexes are thought to bind to the cytoplasmic tails 
of some cellular proteins and to recruit these proteins into 
clathrin-coated pits (Schmid, 1993; Robinson, 1994; Ohno 
et al., 1995). Because the SIV TM has also been implicated 
in interacting with the viral matrix protein (MA) during 
virion formation (Gonzalez et al., 1993), it is possible that 
a TM-MA interaction may be required  to displace enve- 
lope molecules from the adaptor proteins or other compo- 
nents of the endocytic pathway. Indeed, recent findings by 
Mammano et al. have indicated that some determinants in 
the HIV TM may interact with cellular factors and inhibit 
the  association  of  envelope  glycoproteins  with  virions 
(Mammano et al.,  1995).  Thus, it is likely that envelope 
glycoproteins are incorporated into virions through a com- 
plex series of events that involve interactions of their cyto- 
plasmic domains with other viral proteins and with cellular 
components that affect their surface expression and deter- 
mine  their  availability for  uptake  into  virions  (Hunter, 
1994). 
It is unclear if the region of the TM cytoplasmic domain 
that includes Tyr-723 could also be directly involved in the 
incorporation of envelope molecules into virions. Indeed, 
the finding for HIV and SIV that TM molecules lacking a 
cytoplasmic domain can still be incorporated into virions 
suggests that this region may not be critical for viral as- 
sembly (Gabuzda et al., 1992; Salzwedel et al., 1993; Weiss 
and White, 1993;  Johnston et al., 1995). Moreover, enve- 
lope glycoproteins with mutations of this residue are also 
incorporated into virions at similar or even increased lev- 
els  compared  to  wild-type  proteins  (LaBranche  et  al., 
1994, 1995).  However, findings for Moloney murine leuke- 
mia virus have shown that molecules on the plasma mem- 
brane  may be incorporated  into  virions  by two  distinct 
mechanisms, one that is highly efficient and probably de- 
pendent  on a  specific interaction  between the TM cyto- 
plasmic domain and MA and another that is passive, less 
efficient, and dependent primarily on the level of envelope 
expression on the cell surface (Soumalainen and Garoff, 
Sauter et aL SIV Transmembrane Protein Endocytosis Signal  807 Figure  8.  Distribution  of CD4/ 
SIV-TM  and  CD4/LDLr  chi- 
meras  in  HeLa  cells.  HeLa 
cells  stably  expressing  the 
CD4/spacer-723Y  (A),  CD4/ 
spacer-723C  (B),  and  CD4/ 
LDLr chimeras (C), are shown 
after permeabilization  and la- 
beling with an anti-CD4 mAb. 
Staining of HeLa cells not ex- 
pressing  a  chimeric  molecule 
are  also  shown  as  a  control 
(D).  For  both  CD4/spacer- 
723Y  and  the  CD4/LDLr, 
staining  is  concentrated  in  a 
perinuclear  and vesicular pat- 
tern with little  expression seen 
on  the  cell  surface,  while  for 
the  CD4/spacer-723C  chi- 
mera,  staining  is  diffuse  and 
detectable on the cell surface. 
1994). Given the paucity of surface envelope glycoproteins 
on cells infected by SIVs containing the Tyr signal (Fig. 5), 
it is likely that these molecules are incorporated into viri- 
ons with high efficiency. Conversely, envelope molecules 
containing mutated or absent cytoplasmic tails could be in- 
corporated into virions simply as a  reflection of their in- 
creased  level  of expression  on the  cell  surface.  Interest- 
ingly, it has  recently been  shown for alphaviruses  that  a 
highly  conserved  Tyr  in  the  cytoplasmic  domain  of the 
SFV E2 protein,  located eight amino acids from the pre- 
dicted membrane spanning domain, is essential for the ac- 
tive  incorporation  of envelope  glycoproteins into virions 
(Zhao et al., 1994). It is possible that the endocytosis motif 
involving Tyr-723 could also play a role in directing enve- 
lope glycoproteins to virions. 
Finally, the biological effects of a mutation that disrupts 
the SIV internalization signal were evaluated on infectious 
viruses. By comparing two SIVs that differed in the pres- 
ence or absence of a Tyr at position 723, it was shown that 
loss of the internalization signal resulted in accelerated in- 
fection kinetics and a  striking increase  in syncytia forma- 
tion during viral replication. These effects are likely a  di- 
rect  result  of  the  increased  cell  surface  expression  of 
envelope glycoproteins, which have been clearly shown to 
mediate cell fusion (Lifson et al., 1986; Bosch et al., 1989; 
Steffy et al.,  1992) and likely facilitate the spread of virus 
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Figure 9.  Effects of a Tyr-723 
mutation on SIV infection ki- 
.,,"a./xN~  netics.  Viral  supernatants  of 
BK/NC-723Y  (open  squares, 
open  diamonds)  and  BK/NC- 
723C (closed squares, closed di- 
amonds) were normalized to a 
RT level of 10,000 clam (open 
squares,  closed  squares)  or 
1,000  cpm  (open  diamonds, 
: ~-  ~-  .....  closed diamonds), and used to 
10  20  30  40  so  60  70  inoculate  Sup-T1  cells.  Cul- 
Days  Post Infeclk)n  tures  were  monitored  for  in- 
fection by: (a) immunofluores- 
cence using antibodies against p27gag; and (b) RT activity in culture supernatants at the indicated time points. As shown, at high and low 
inoculations, viruses containing the Tyr to Cys mutation at position 723 exhibit more rapid infection kinetics and more extensive spread 
of infection in the culture. 
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to  Cys  mutation  on  syncytia 
formation.  Sup-T1  cells  from 
the experiment shown in Fig. 9 
were stained  by IFA for viral 
antigen  expression  (p27gag). 
(A) Cells infected by BK/NC- 
723Y on day 49 after inocula- 
tion; (B) Cells infected by BK/ 
NC-723C on day 35 after inoc- 
ulation.  A  large  syncytium  is 
evident  for  BK/NC-723C, 
while only single antigen-posi- 
tive  cells  are  present  during 
BK/NC-723Y infection. 
infection from cell to cell (Dimitrov et al., 1993). Interest- 
ingly, although BK/NC-723C infection in the culture was 
more rapid and eventually involved nearly all cells, the on- 
set of infection remained delayed, suggesting that the in- 
fectivity of the viral particles per se was not enhanced. In- 
fection of Sup-T1 cells by NC-MAC has been shown to be 
noncytopathic and slow, thus enabling the effects of this 
mutation to be readily apparent. Whether or not similar 
mutations  would  alter  infectivity of viruses  that  exhibit 
rapid and cytopathic infection kinetics remains to be de- 
termined. Nonethess, it is apparent that in some circum- 
stances, mutations that disrupt this internalization signal 
can produce biological alterations in the virus. Although 
the significance of these findings for in vivo infection re- 
mains unclear, an HIV-1 containing a Tyr to Cys mutation 
at the analogous position in the TM cytoplasmic domain 
has recently been reported from a patient with advanced 
HIV infection and a high viral load (Gao et al., 1996). The 
relationship of this mutation to the in vivo properties of 
this virus remains to be determined. 
These findings indicate that a  determinant in the  SIV 
TM cytoplasmic tail has evolved to mimick a cellular sig- 
nal that is widely used to remove proteins from the cell 
surface. Although just one component of the complex bi- 
ology of the  virus,  it  is  clear from the  experiments  de- 
scribed here that this signal can contribute to the infectiv- 
ity and cytopathic properties of SIV in culture, and may 
also be important for the pathogenesis of these viruses in 
vivo. By reducing the level of envelope glycoprotein on 
the surface of infected cells this signal could modulate the 
susceptibility  of  infected  cells  to  humoral  immune  re- 
sponses and contribute to the ability of the virus to estab- 
lish a persistent infection in vivo. Thus, only proteins ac- 
tively being incorporated into progeny virions would be 
present on the cell surface, while the remainder would be 
removed via the endocytic pathway. Endocytosis of viral 
glycoproteins could  also  play  a  role  in  altering  cellular 
anti-viral immune responses by enabling these proteins to 
be processed for presentation by HLA class II molecules 
(Rowell et al., 1995). Finally, it is possible that an endocy- 
tosis signal could play a role during viral entry by helping 
to clear envelope glycoproteins that are deposited in the 
plasma membrane following fusion of the virion with the 
cell. Of note, SIVs that contain mutations of Tyr-723 are 
replication competent in macaque peripheral blood lym- 
phocytes  (Fultz,  P.,  personal  communication).  It  will 
therefore be possible to evaluate the effects of this muta- 
tion on the natural history of viral infection in vivo as well 
as on the immune responses in infected animals. 
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